Evidence-based Pharmacy Practice (EBPP): Gastroenteritis in children
Abstract
Diarrhoea is one of the most common causes of morbidity and mortality in children worldwide.1 It causes the death of about two million children under the age of five years each year. 2 Acute gastroenteritis results from infection of the gastrointestinal tract most commonly with a virus, the most common being rotavirus.3 Campylobacter and Salmonella are the most common bacterial pathogens; Cryptosporidium and Giardia are the most common parasites that can cause diarrhoea.Chronic diarrhoea suggests a non-infective cause such as inflammatory bowel disease or coeliac disease.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.